GSE128848
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple mutated AML
HLF was knocked down in a primary human triple mutated AML sample using shRNA against human HLF versus shRNA against luciferase (shLuc) as control to determine gene expression changes 72 hours after lentiviral transduction. Overall design: Transcriptome profiling of shRNA mediated HLF knockdown cells in primary AML cells.